NEOS Investment Management LLC Boosts Position in Axon Enterprise, Inc $AXON

NEOS Investment Management LLC raised its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 82.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,369 shares of the biotechnology company’s stock after purchasing an additional 11,482 shares during the period. NEOS Investment Management LLC’s holdings in Axon Enterprise were worth $18,206,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of AXON. Stone House Investment Management LLC purchased a new position in shares of Axon Enterprise in the 3rd quarter valued at $29,000. Whipplewood Advisors LLC boosted its stake in Axon Enterprise by 192.9% in the second quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock valued at $34,000 after acquiring an additional 27 shares in the last quarter. Darwin Wealth Management LLC purchased a new position in shares of Axon Enterprise during the second quarter worth about $37,000. Root Financial Partners LLC acquired a new stake in shares of Axon Enterprise during the third quarter worth about $34,000. Finally, NewSquare Capital LLC lifted its holdings in shares of Axon Enterprise by 96.2% in the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after purchasing an additional 25 shares during the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $431.94 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 3.12 and a quick ratio of 2.89. The firm has a market cap of $34.08 billion, a price-to-earnings ratio of 136.69, a price-to-earnings-growth ratio of 12.94 and a beta of 1.48. The firm’s fifty day moving average price is $552.80 and its 200 day moving average price is $642.97. Axon Enterprise, Inc has a 1-year low of $396.41 and a 1-year high of $885.91.

Insiders Place Their Bets

In related news, CFO Brittany Bagley sold 2,000 shares of the firm’s stock in a transaction dated Thursday, December 11th. The shares were sold at an average price of $580.00, for a total value of $1,160,000.00. Following the completion of the sale, the chief financial officer owned 103,501 shares in the company, valued at $60,030,580. This trade represents a 1.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jeri Williams sold 100 shares of Axon Enterprise stock in a transaction that occurred on Thursday, December 4th. The shares were sold at an average price of $550.63, for a total value of $55,063.00. Following the completion of the sale, the director directly owned 1,316 shares in the company, valued at $724,629.08. This represents a 7.06% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 48,040 shares of company stock valued at $27,249,338. Corporate insiders own 5.70% of the company’s stock.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research reports. William Blair restated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Monday, December 29th. TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Royal Bank Of Canada started coverage on shares of Axon Enterprise in a research report on Monday, November 17th. They set an “outperform” rating and a $860.00 price objective on the stock. Finally, UBS Group dropped their price objective on shares of Axon Enterprise from $840.00 to $610.00 and set a “neutral” rating on the stock in a research note on Wednesday, November 5th. Fifteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $805.71.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.